RecruitingPhase 1Drug trialPrP-targeting siRNA Safety & Mechanism StudyThe purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.